A study by Bai et al. [43] suggested that IRF1 and IRF8 might be potential regulators of the SPHK1 (the sphingosine pathway promotes vascular remodeling and induces PAH) overexpression gene set signature in human PASMCs. The gene discussed is IRF1; the disease is pulmonary arterial hypertension.